BioNTech
BNTX
BNTX
280 hedge funds and large institutions have $4.34B invested in BioNTech in 2023 Q4 according to their latest regulatory filings, with 70 funds opening new positions, 90 increasing their positions, 69 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
1.92% more ownership
Funds ownership: 15.4% → 17.32% (+1.9%)
5% more call options, than puts
Call options by funds: $234M | Put options by funds: $224M
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
Holders
280
Holding in Top 10
4
Calls
$234M
Puts
$224M
Top Buyers
| 1 | +$411M | |
| 2 | +$71.3M | |
| 3 | +$30.7M | |
| 4 |
Amundi
Paris,
France
|
+$24.2M |
| 5 |
UBS AM
Chicago,
Illinois
|
+$14.5M |
Top Sellers
| 1 | -$70.8M | |
| 2 | -$37.9M | |
| 3 | -$35.1M | |
| 4 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$21.7M |
| 5 |
CGI
Comgest Global Investors
Paris,
France
|
-$20.4M |